Literature DB >> 9148934

Overexpression of the G1-cyclin gene CLN2 represses the mating pathway in Saccharomyces cerevisiae at the level of the MEKK Ste11.

K Wassmann1, G Ammerer.   

Abstract

Basal and induced transcription of pheromone-dependent genes is regulated in a cell cycle-dependent way. FUS1, a gene strongly induced after pheromone treatment, shows high mRNA levels in mitosis and early G1 phase of the cell cycle, a decrease in G1 after START and again an increase in S phase. Overexpression of CLN2 was shown to repress the transcript number of pheromone-dependent genes (1). We asked whether the activities of components of the mating pathway fluctuate during the cell cycle. We were also interested in determining at what level Cln2 represses the signal transduction machinery. Here we show that the activity of the mitogen-activated protein kinase Fus3 indeed fluctuates during the cell cycle, reflecting the oscillations of the gene transcripts. CLN2 overexpression represses Fus3 kinase activity, independently of the phosphatase Msg5. Additionally, we show that the activity of the MEK Ste7 also fluctuates during the cell cycle. Increased Cln2 levels repress the ability of hyperactive STE11 alleles to induce the pathway. G protein-independent activation of Ste11 caused by an rga1 pbs2 mutation is resistant to high levels of Cln2 kinase. Therefore our results suggest that Cln2-dependent repression of the mating pathway occurs at the level of Ste11.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9148934     DOI: 10.1074/jbc.272.20.13180

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Counteractive control of polarized morphogenesis during mating by mitogen-activated protein kinase Fus3 and G1 cyclin-dependent kinase.

Authors:  Lu Yu; Maosong Qi; Mark A Sheff; Elaine A Elion
Journal:  Mol Biol Cell       Date:  2008-02-06       Impact factor: 4.138

2.  Cyclin-specific docking motifs promote phosphorylation of yeast signaling proteins by G1/S Cdk complexes.

Authors:  Samyabrata Bhaduri; Peter M Pryciak
Journal:  Curr Biol       Date:  2011-09-22       Impact factor: 10.834

3.  Isolation and characterization of new alleles of the cyclin-dependent kinase gene CDC28 with cyclin-specific functional and biochemical defects.

Authors:  K Levine; L J Oehlen; F R Cross
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

4.  An overview of Cdk1-controlled targets and processes.

Authors:  Jorrit M Enserink; Richard D Kolodner
Journal:  Cell Div       Date:  2010-05-13       Impact factor: 5.130

5.  Fus3p and Kss1p control G1 arrest in Saccharomyces cerevisiae through a balance of distinct arrest and proliferative functions that operate in parallel with Far1p.

Authors:  V Cherkasova; D M Lyons; E A Elion
Journal:  Genetics       Date:  1999-03       Impact factor: 4.562

6.  Regulation of G2/M progression by the STE mitogen-activated protein kinase pathway in budding yeast filamentous growth.

Authors:  S H Ahn; A Acurio; S J Kron
Journal:  Mol Biol Cell       Date:  1999-10       Impact factor: 4.138

Review 7.  Cdc42: An essential Rho-type GTPase controlling eukaryotic cell polarity.

Authors:  D I Johnson
Journal:  Microbiol Mol Biol Rev       Date:  1999-03       Impact factor: 11.056

8.  A mechanism for cell-cycle regulation of MAP kinase signaling in a yeast differentiation pathway.

Authors:  Shelly C Strickfaden; Matthew J Winters; Giora Ben-Ari; Rachel E Lamson; Mike Tyers; Peter M Pryciak
Journal:  Cell       Date:  2007-02-09       Impact factor: 41.582

Review 9.  MAP kinase pathways in the yeast Saccharomyces cerevisiae.

Authors:  M C Gustin; J Albertyn; M Alexander; K Davenport
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

10.  Nucleus-specific and cell cycle-regulated degradation of mitogen-activated protein kinase scaffold protein Ste5 contributes to the control of signaling competence.

Authors:  Lindsay S Garrenton; Andreas Braunwarth; Stefan Irniger; Ed Hurt; Markus Künzler; Jeremy Thorner
Journal:  Mol Cell Biol       Date:  2008-11-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.